**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 109-02-4 |N-Methylmorpholine | >99 | 203-640-0 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: F C
Risk Phrases: 11 20/21/22 34
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Highly flammable. Harmful by inhalation, in contact with skin and if
swallowed. Causes burns.
Potential Health Effects
Eye:
Causes moderate eye irritation. May cause eye burns. May cause
conjunctivitis.
Skin:
Causes skin irritation. May be absorbed through the skin in harmful
amounts. May cause skin burns.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and
diarrhea. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. Irritation may lead to chemical
pneumonitis and pulmonary edema.
Chronic:
Prolonged or repeated skin contact may cause defatting and
dermatitis.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately. Do NOT allow victim to rub eyes or keep eyes closed.
Extensive irrigation with water is required (at least 30 minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Discard contaminated clothing in a manner which limits
further exposure. Destroy contaminated shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid if cough or other symptoms
appear. Do NOT use mouth-to-mouth resuscitation. If breathing has
ceased apply artificial respiration using oxygen and a suitable
mechanical device such as a bag and a mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Vapors can travel to a source of ignition and flash
back. During a fire, irritating and highly toxic gases may be
generated by thermal decomposition or combustion. Flammable Liquid.
Can release vapors that form explosive mixtures at temperatures above
the flashpoint. Use water spray to keep fire-exposed containers cool.
Vapors may be heavier than air. They can spread along the ground and
collect in low or confined areas.
Extinguishing Media:
For small fires, use dry chemical, carbon dioxide, water spray or
alcohol-resistant foam. Use water spray to cool fire-exposed
containers. Cool containers with flooding quantities of water until
well after fire is out.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Use water spray to dilute spill to a non-flammable mixture. Avoid
runoff into storm sewers and ditches which lead to waterways. Clean
up spills immediately, observing precautions in the Protective
Equipment section. Scoop up with a nonsparking tool, then place into
a suitable container for disposal. Remove all sources of ignition.
Absorb spill using an absorbent, non-combustible material such as
earth, sand, or vermiculite. Do not use combustible materials such as
sawdust. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Follow all MSDS and
label precautions even after container is emptied because they may
contain product residues. Use spark-proof tools and explosion proof
equipment. Do not get in eyes, on skin, or on clothing. Empty
containers retain product residue, (liquid and/or vapor), and can be
dangerous. Keep container tightly closed. Do not ingest or inhale. Do
not pressurize, cut, weld, braze, solder, drill, grind, or expose
empty containers to heat, sparks or open flames.
Storage:
Keep away from sources of ignition. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances. Flammables-area.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Always use
a NIOSH or European Standard EN 149 approved
respirator when necessary.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless
Odor: strong odor - ammonia-like
pH: 10.6 (50g/L water)
Vapor Pressure: 5 mm Hg @ 20C
Viscosity: 0.9 mPa s 20 C
Boiling Point: 239 deg F
Freezing/Melting Point: -87 deg F
Autoignition Temperature: 329 deg F ( 165.00 deg C)
Flash Point: 75 deg F ( 23.89 deg C)
Explosion Limits, lower: 2.2
Explosion Limits, upper: 11.8
Decomposition Temperature: Not available.
Solubility in water: Soluble in water.
Specific Gravity/Density: 0.9 (water=1)
Molecular Formula: C5H11NO
Molecular Weight: 101.15
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Ignition sources.
Incompatibilities with Other Materials:
Acids, acid chlorides, acid anhydrides, carbon dioxide, strong
oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 109-02-4: QE5775000
LD50/LC50:
CAS# 109-02-4: Draize test, rabbit, eye: 920 ug Severe; Draize test,
rabbit, eye: 20 mg/24H Mild; Inhalation, mouse: LC50 = 25200
mg/m3/2H; Oral, mouse: LD50 = 1970 mg/kg; Oral, rat: LD50 = 1960
mg/kg; Skin, rabbit: LD50 = 1350 uL/kg; Skin, rat: LD50 = 1820 mg/kg.
Carcinogenicity:
N-Methylmorpholine -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Products which are considered hazardous for supply are classified as Special
Waste and the disposal of such chemicals is covered by regulations which may
vary according to location. Contact a specialist disposal company or the local
waste regulator for advice. Empty containers must be decontaminated before
returning for recycling.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: F C
Risk Phrases:
R 11 Highly flammable.
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 34 Causes burns.
Safety Phrases:
S 16 Keep away from sources of ignition - No
smoking.
S 25 Avoid contact with eyes.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 109-02-4: 1
United Kingdom Occupational Exposure Limits
United Kingdom Maximum Exposure Limits
Canada
CAS# 109-02-4 is listed on Canada's DSL List.
CAS# 109-02-4 is listed on Canada's Ingredient Disclosure List.
Exposure Limits
CAS# 109-02-4: OEL-RUSSIA:STEL 5 mg/m3;Skin
OEL-SWEDEN:TWA 5 ppm (20 mg/m3);STEL 10 ppm (40 mg/m3);Skin
US FEDERAL
TSCA
CAS# 109-02-4 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 2/10/1999 Revision #2 Date: 10/18/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
N-Butyl Chloride
| 109-69-3 |
|
2,4-Hexadiene, 99%, Mixture of Isomers
| 592-46-1 |
|
3,5-Dichloro-2-Hydroxybenzenesulfonyl Chloride, 90-95%(Cl)
| 23378-88-3 |
|
1-Cyano-3-methylisothiourea, sodium salt, 94+%
| 67944-71-2 |
|
3-Methylbutyraldehyde, 98%
| 590-86-3 |
|
Styrene-d8, stabilized, 98+ atom% D
| 100-42-5 |
|
Calcium Iodide Tetrahydrate, 99%
| 13640-62-5 |
|
n-Butylamine
| 109-73-9 |
|
Glycine Tert-Butyl Ester Hydrochloride 99% (tlc)
| 27532-96-3 |
|
1-Bromo-2,4,5-Trifluorobenzene 99%
| 327-52-6 |
|
Decane
| 124-18-5 |
|
4'-Methoxyacetanilide, 99+%
| 51-66-1 |
|
2,6-Pyridinedimethanol, 98%
| 1195-59-1 |
|
4-Cyanobenzyltriphenylphosphonium chloride, 98%
| 20430-33-5 |
|
3-Amino-2,4,6-Triiodobenzoic Acid, 99+%
| 3119-15-1 |
|
Tert.-butyl sulfide, 98%
| 107-47-1 |
|
Methoxyacetic acid, 98%
| 625-45-6 |
|
2,4-Dichloropyrimidine, 97%
| 3934-20-1 |
|
2-Propanethiol, 98%
| 75-33-2 |
|
2,2'-Dimethoxybiphenyl, 98%
| 4877-93-4 |
|
3,5-Diiodo-l-tyrosine
| 300-39-0 |
|
Butyl 4-hydroxybenzoate
| 94-26-8 |
|
Ethynylestradiol 3-methyl ether, 97%
| 72-33-3 |
|
Triallylamine, 98%
| 102-70-5 |
|
1-Hydroxy-2,2,4,5,5-pentamethyl-3-imidazoline, 98%
| 39753-73-6 |
|
11-alpha-Hydroxyprogesterone, 95%
| 80-75-1 |
|
4-Phenylbutyric Acid, 97% (Titr.)
| 1821-12-1 |
|
Triisopentylamine, 99% (GC)
| 645-41-0 |
|
2'-Deoxycytidine Monohydrate, 99+%
| 951-77-9 |
|
8-(Diethylamino)Octyl 3,4,5-Trimethoxy-Benzoate Hydrochloride, 97%
| 53460-46-1 |
|
Hexamethylbenzene
| 87-85-4 |
|
2,2-Dichlorodiethylether, 99+%
| 111-44-4 |
|
3,3'-Carbonylbis(7-methoxycoumarin)
| 64267-17-0 |
|
2-Benzoylpyridine, 99+%
| 91-02-1 |
|
d-(-)-s-Acetyl-beta-mercaptoisobutyric acid, 99%
| 76497-39-7 |
|
1,3-Propanedithiol, 98% (gc)
| 109-80-8 |
|
3-Methylphenethyl Alcohol , 98%
| 1875-89-4 |
|
Oxalyl dihydrazide, 98%
| 996-98-5 |
|
Diphenylboric acid, ethanolamine complex 98%
| 524-95-8 |
|
N-Methylmorpholine
| 109-02-4 |
|
Hexacosane, 99%
| 630-01-3 |
|
Chromotropic Acid, Sodium Salt(Techn), 60% (Titr.)
| 3888-44-6 |
|
2-Chlorobenzyl Alcohol, 99%
| 17849-38-6 |
|
Di-n-octylamine (Pract), 95% (GC)
| 1120-48-5 |
|
1,2,4-Benzenetricarboxylic anhydride, 97%
| 552-30-7 |
|
Triphenylcarbenium hexafluorophosphate, 99%
| 437-17-2 |
|
(2R,3S)-2-Amino-3-Phenylthiobutanoic Acid, Hydrochloride, 99+% (80%
| 0-01-1 |
|
Hexafluorophosphoric Acid, 60 WT% Solution in Water
| 7732-18-5 |
|
4-(4-Anilinophenylazo)Benzenesulfonic Acid Sodium Salt, Indicator
| 554-73-4 |
|
5-Bromo-2-thiophenecarboxaldehyde, 97%
| 4701-17-1 |
|
|